Metabolic tumour volume: Prognostic value in locally advanced squamous cell carcinoma of the head and neck

NuklearMedizin

Volumn 50, Issue 4, 2011, Pages 141-146

  Deron, P ^a   Mertens, K ^a   Goethals, I ^a   Rottey, S ^a   Duprez, F ^a   de Neve, W ^a   Vermeersch, H ^a   van de Wiele, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

FDG PET; Locally advanced SCCHN; Prognosis

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LYMPH NODE; MALE; MOUTH CARCINOMA; NECK DISSECTION; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80051609403     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/Nukmed-0367-10-11     Document Type: Article

References (28)

1. Allal A, Dulguerov P, Allaoua M et al. Standardized uptake value of 2-(18F) fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with and without chemotherapy. J Clin Oncol 2002; 20: 1398-1404.
2. Allal A, Slosman D, Kebdani T et al. Prediction of outcome in head-and-neck cancer patients using standardized uptake value of 2-(18F) fluoro- 2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 2004; 59: 1295-1300.
3. Argiris A, Karamouzis M, Raben D, Ferris R. Head and neck cancer. Lancet 2008; 371: 1695-1709.
4. Brun E, Kjellén E, Tennvall J et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002; 24: 127-135.
5. Byers R, Clayman G, Guillamondequi O et al. Resection of advanced cervical metastasis prior to definitive radiotherapy for squamous carcinomas of the upper aerodigestive tract. Head Neck 1992; 14: 133-138.
6. Ciernik I, Dizendorf E, Baumert B et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasability study. Int J Radiat Oncol Biol Phys 2003; 57: 853-863.
7. Cooper J, Porter K, Mallin K. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009; 31: 748-758.
8. Dequanter D, Lothaire P, Awada A et al. Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck? Acta Otolaryngol 2006; 126: 1225-1228.
9. Doweck I, Denys D, Robbins K. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemotherapy. Laryngoscope 2002; 112: 1742-1749.
10. Duprez F, De Neve W, De Gersem W et al. Adaptive dose painting by numbers for head-and-neck cancer. IJRBOP 2010: 1-11.
11. Duvvuri U, Myers J. Cancer of the head and neck is the sixth common cancer worldwide. Curr Probl Surg 2009; 46: 114-117.
12. Frank D, Hu K, Culliney B et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 2005; 115: 1015-1020.
13. Grabenbauer G, Steininger H, Meyer M et al. Nodal CT density and tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol 1998; 47: 175-183.
14. Halfpenny W, Hain S, Biassoni L et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 2002; 86: 512-516.
15. Kitagawa Y, Sano K, Nishizawa S et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med 2003; 30: 63-71.
16. Knegjens J, Hauptman M, Pameijer F et al. Tumor volume as outcome predictor in chemoradiation for advanced head and neck cancer. Head Neck 2011; 33: 375-382.
17. La T, Filion E, Turnbull B et al. Metabolic tumor volume predicts for recurrence and death in head-andneck cancer. Int J Radiat Oncol Biol Phys 2009; 74: 1335-1341.
18. Linecker A, Kermer C, Sulzbacher I et al. Uptake of 18F-FLT and 18F-FDG in primary head and neck cancer correlates with survival. Nuklearmedizin 2008; 47: 80-85.
19. Minn H, Lapela M, Klemi P et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997; 38: 1907-1911.
20. Pignon J, le Maître A, Maillard E, Bourhis J. Metaanalysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17 346 patients. Radiother Oncol 2009; 92: 4-14.
21. Plataniotis G, Theofanopoulou M, Kalogera-Fountzila A et al. Prognostic impact of tumor volumetry in patients with locally advanced head-andneck cancer (non-nasopharyngeal) treated by radiotherapy alone or combined with radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 2004; 59: 1018-1026.
22. Schmidt M, Schmalenbach M, Jungehülsing M et al. 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin 2004; 43: 91-101.
23. Smeele L, Leemans C, Reid C et al. Neck dissection for advanced lymph node metastasis before definitive radiotherapy for primary carcinoma of the head and neck. Laryngoscope 2000; 110: 1210-1214.
24. Suzuki H, Hasegawa Y, Terada A et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncology 2009; 45: 569-573.
25. Torizuka T, Tanizaki Y, Kanno T et al. Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. Am J Roentgenol 2009; 192: W156-W160.
26. Vermeersch H, Loose D, Ham H et al. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers. Eur J Nucl Med 2003; 30: 1689-1700.
27. Vernon M, Maheshwari M, Schultz C et al. Clinical outcomes of patients receiving integrated PET/CTguided radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 70: 678-684.
28. Xie P, Yue J, Zhao H et al. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2010; 136: 883-889